Heidelberg Pharma AG (LON:0QW5)

Heidelberg Pharma AG Ratios and Metrics

Market cap in millions GBP. Fiscal year is December - November.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 14, 2025	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020	Nov 30, 2019
Market Capitalization	89	111	230	151	145	53
Market Cap Growth	-28.65%	-51.85%	52.81%	4.13%	172.95%	-25.19%
Enterprise Value	59	72	235	139	137	42
Last Close Price	1.95	2.41	4.43	5.70	3.42	2.69
PS Ratio	13.81	13.05	14.39	87.04	18.64	8.30
PB Ratio	3.27	2.61	4.00	26.43	12.54	3.82
P/TBV Ratio	4.34	3.18	4.62	-	40.90	8.43
EV/Sales Ratio	8.46	8.49	14.67	80.41	17.60	6.61
Debt / Equity Ratio	0.00	0.12	0.24	1.59	0.02	-
Asset Turnover	0.12	0.12	0.30	0.10	0.41	0.28
Inventory Turnover	0.16	0.43	1.76	9.66	23.96	18.01
Quick Ratio	4.55	2.31	2.96	0.51	0.98	1.75
Current Ratio	6.01	2.86	3.15	0.60	1.13	1.79
Return on Equity (ROE)	-42.99%	-35.08%	-53.73%	-267.02%	-125.93%	-48.12%
Return on Assets (ROA)	-19.45%	-20.14%	-18.69%	-78.14%	-56.00%	-24.23%
Return on Capital (ROIC)	-29.23%	-24.99%	-22.88%	-106.22%	-81.22%	-31.13%
Earnings Yield	-17.67%	-15.82%	-7.39%	-14.77%	-11.37%	-16.31%
FCF Yield	-28.49%	-26.91%	-3.55%	-15.74%	-11.92%	-15.20%
Buyback Yield / Dilution	1.26%	-25.14%	-14.56%	-8.72%	-5.98%	0.00%
Total Shareholder Return	1.26%	-25.14%	-14.56%	-8.72%	-5.98%	0.00%

Source: S&P Capital IQ. Standard template. Financial Sources.